Exscientia Plc - stock earnings
EXAI Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -38.1 million USD | 10.8 million USD |
2023Q2 | -45.4 million USD | 3.8 million USD |
2023Q1 | -46.6 million USD | 7.1 million USD |
2022Q4 | -57.0 million USD | 9.9 million USD |
2022Q3 | -44.0 million USD | 7.8 million USD |
2022Q2 | -24.7 million USD | 11.1 million USD |
2022Q1 | -26.7 million USD | 12.0 million USD |
2021Q4 | -27.2 million USD | 5.6 million USD |
2021Q3 | -9.2 million USD | 31.9 million USD |
2021Q2 | -35.6 million USD | 558859 USD |
2021Q1 | -10.4 million USD | 10.0 million USD |
2020Q4 | -14.2 million USD | 8.0 million USD |
2020Q3 | -13.9 million USD | 1.6 million USD |
2020Q2 | -6.9 million USD | 3.0 million USD |
2020Q1 | -6.9 million USD | 3.0 million USD |
2019Q4 | -2.1 million USD | 3.0 million USD |
2019Q3 | -2.0 million USD | 2.8 million USD |
2019Q2 | -2.0 million USD | 2.9 million USD |
2019Q1 | -2.1 million USD | 3.0 million USD |
EXAI Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -183.3 million USD | 31.2 million USD |
2022 | -173.3 million USD | 39.8 million USD |
2021 | -66.6 million USD | 37.1 million USD |
2020 | -41.5 million USD | 18.0 million USD |
2019 | -10.9 million USD | 15.7 million USD |
EXAI
Price: $5
52 week price:
Earnings Per Share: -1.49 USD
P/E Ratio: -4.02
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 445040
Market Capitalization: 626.8 million